Clinical Trials Browser

Unknown × Mesothelioma × Imatinib Mesylate × Clear all

NCT00551252 2007-10-30

A Phase II Study of the Association of Glivec® Plus Gemzar® in Patients With Unresectable, Refractory, Malignant Mesothelioma

Phase 2 Unknown

Other solid neoplasmThoracic

Mesothelioma